Cita APA

Camelo, S., Latil, M., Veillet, S., Dilda, P. J., & Lafont, R. (2020). Beyond AREDS Formulations, What Is Next for Intermediate Age-Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti-inflammatory Apocarotenoids as Neuroprotectors. Oxid Med Cell Longev.

Citación estilo Chicago

Camelo, Serge, Mathilde Latil, Stanislas Veillet, Pierre J. Dilda, and René Lafont. "Beyond AREDS Formulations, What Is Next for Intermediate Age-Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti-inflammatory Apocarotenoids As Neuroprotectors." Oxid Med Cell Longev 2020.

Cita MLA

Camelo, Serge, et al. "Beyond AREDS Formulations, What Is Next for Intermediate Age-Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti-inflammatory Apocarotenoids As Neuroprotectors." Oxid Med Cell Longev 2020.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.